Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
April 3, 2020—(BRONX, NY)—Montefiore Health System andAlbert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial. This treatment has the potential to help people who have serious lung complications as a result of COVID-19. Recruitment for the trial began in March and is still underway. (Source: Einstein News)
Source: Einstein News - April 3, 2020 Category: Universities & Medical Training Source Type: news

Clement Tagoe, M.D., Ph.D., Named Chief of Rheumatology
March 23, 2020—(BRONX, NY)—Clement Tagoe, M.D., Ph.D., has been named chief of the Division of Rheumatology at Einstein and Montefiore, effective April 1. He replaces Chaim Putterman, M.D., who helped make the rheumatology division a national leader in its field during his 26 years here. (Source: Einstein News)
Source: Einstein News - March 23, 2020 Category: Universities & Medical Training Source Type: news

Einstein Students Learn Match Results Amid COVID-19 Crisis
March 20, 2020—(BRONX, NY)—Amid a sobering global pandemic with medical professionals performing heroic work around the world, fourth-year medical students ofAlbert Einstein College of Medicine, a part ofMontefiore, learned today by email where they will begin their residencies at hospitals across the nation. (Source: Einstein News)
Source: Einstein News - March 20, 2020 Category: Universities & Medical Training Source Type: news

Experimental Drug May Prevent Chemotherapy Drug from Damaging the Heart
March 3, 2020—(BRONX, NY)—The commonly used chemotherapy drug doxorubicin can damage heart muscle, in some cases leading to severe or lethal heart failure. A new study led byAlbert Einstein College of Medicine researchers and involving zebrafish and mice suggests that the experimental drug BAI1 can prevent doxorubicin from damaging the heart without lessening its anti-cancer properties. The study was published online in the journalNature Cancer. (Source: Einstein News)
Source: Einstein News - March 3, 2020 Category: Universities & Medical Training Source Type: news

Michelle Ng Gong, M.D., M.S., Named Chief of Division of Pulmonary Medicine
February 21, 2020—(BRONX, NY)—Michelle Ng Gong, M.D., M.S., an internationally renowned clinician and researcher, has been named chief of the division of pulmonary medicine atAlbert Einstein College of Medicine andMontefiore Health System. Dr. Gong is currently chief of the division of critical care medicine at Einstein and Montefiore, as well as leader of the unified Jay B. Langer Critical Care Network. (Source: Einstein News)
Source: Einstein News - February 21, 2020 Category: Universities & Medical Training Source Type: news

Susan Band Horwitz Wins Prestigious Cancer Research Award for Anti-Tumor Drug Discovery
February 14, 2020—(BRONX, NY)—Susan Band Horwtiz, Ph.D., distinguished professor of molecular pharmacology and the Rose C. Falkenstein Chair in Cancer Research at Albert Einstein College of Medicine, has been awarded the National Foundation for Cancer Research’s (NFCR) 2020 Szent-Györgyi Prize for Progress in Cancer Research. The honor recognizes her pioneering research establishing the mechanism of action of anti-tumor drugs, including Taxol, that are used to treat ovarian, breast, and lung cancers. (Source: Einstein News)
Source: Einstein News - February 14, 2020 Category: Universities & Medical Training Source Type: news

Montefiore and Albert Einstein College of Medicine Secure $5.9 Million NCI Grant to Improve Cancer Care for Minority and Underserved Communities
January 29, 2020—(BRONX, NY)—Montefiore, the University Hospital ofAlbert Einstein College of Medicine, has received a $5.9 million grant from the National Cancer Institute (NCI) to build on its success recruiting minority and underserved patients into cancer clinical trials and delivering the highest quality cancer care. This new grant, part of the NCI Community Oncology Research Program (NCORP), is a continuation of funding first awarded in 2014. (Source: Einstein News)
Source: Einstein News - January 29, 2020 Category: Universities & Medical Training Source Type: news

Reducing Blood Cancer Patients' Need for Transfusions
January 21, 2020—(BRONX, NY)—A clinical trial has found the drug luspatercept significantly reduced the need for blood transfusions in people with lower-risk myelodysplastic syndromes (MDS), a group of bone marrow disorders that leave people with many defective blood cells and too few normal ones. Approval by the Food and Drug Administration (FDA) would make luspatercept the first new drug available to MDS patients in 12 years.Results of the phase 3 clinical trial were published online January 9 in the New England Journal of Medicine (NEJM). (Source: Einstein News)
Source: Einstein News - January 21, 2020 Category: Universities & Medical Training Source Type: news

Einstein and Montefiore Receive Accreditation for Interprofessional Continuing Education
January 16, 2020—(BRONX, NY)—Albert Einstein College of Medicine andMontefiore Health System have received Joint Accreditation for Interprofessional Continuing Education, certifying their ability to provide interprofessional continuing education (IPCE) for members of the medical profession, including physicians, nurses, and pharmacists. Einstein and Montefiore join fewer than 25 combined medical schools and health systems nationally that have received IPCE accreditation. (Source: Einstein News)
Source: Einstein News - January 16, 2020 Category: Universities & Medical Training Source Type: news

Einstein ’s 2020 Stem Cell Symposium Spotlights RNA Biology and Gene Editing
January 13, 2020—(BRONX, NY)—On Friday, January 17, Albert Einstein College of Medicine will host its 4th Stem Cell Symposium. This year’s event will feature lectures from leading investigators in the fields of RNA biology and the use of gene editing in stem cell research. (Source: Einstein News)
Source: Einstein News - January 13, 2020 Category: Universities & Medical Training Source Type: news

Einstein and Montefiore Present Research and Clinical Advances at American Society of Hematology Annual Meeting
Researchers and clinicians fromAlbert Einstein College of Medicine andMontefiore Health System were well-represented at the 61st American Society of Hematology (ASH) Annual Meeting& Exposition in Florida, the world’s largest gathering of experts who treat and study blood diseases. Faculty members delivered 12 oral presentations and dozens of poster presentations at the conference, which attracted more than 30,000 participants and showcased the latest advances in hematology. (Source: Einstein News)
Source: Einstein News - December 23, 2019 Category: Universities & Medical Training Source Type: news

Einstein Receives $178 Million in NIH Funding in Fiscal Year 2019, Largest Annual Total in Institution's History
December 10, 2019—BRONX, NY— Researchers atAlbert Einstein College of Medicine secured $178 million from the National Institutes of Health in federal fiscal year 2019, marking the largest annual total in the institution’s history (excluding supplemental stimulus funding distributed as a part of the American Recovery and Reinvestment Act of 2009). Major grants included those to lead international consortiums to study Ebola and HIV, as well as those focusing on neuroscience, genetics, and improving health among minority groups. (Source: Einstein News)
Source: Einstein News - December 10, 2019 Category: Universities & Medical Training Source Type: news